Two Sigma Advisers’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-149,600
| Closed | -$17.4M | – | 2324 |
|
|
2025
Q1 | $17.4M | Buy |
149,600
+143,300
| +2,275% | +$16.7M | 0.04% | 364 |
|
|
2024
Q4 | $533K | Buy |
6,300
+2,900
| +85% | +$245K | ﹤0.01% | 1750 |
|
|
2024
Q3 | $306K | Buy |
+3,400
| New | +$306K | ﹤0.01% | 1902 |
|
|
2022
Q2 | – | Sell |
-37,800
| Closed | -$1.57M | – | 2656 |
|
|
2022
Q1 | $1.57M | Buy |
37,800
+6,500
| +21% | +$269K | ﹤0.01% | 1391 |
|
|
2021
Q4 | $1.18M | Sell |
31,300
-2,800
| -8% | -$106K | ﹤0.01% | 1475 |
|
|
2021
Q3 | $1.12M | Sell |
34,100
-14,400
| -30% | -$475K | ﹤0.01% | 1557 |
|
|
2021
Q2 | $3.27M | Sell |
48,500
-81,200
| -63% | -$5.48M | 0.01% | 1064 |
|
|
2021
Q1 | $7.34M | Buy |
129,700
+48,400
| +60% | +$2.74M | 0.02% | 693 |
|
|
2020
Q4 | $6.62M | Sell |
81,300
-26,600
| -25% | -$2.17M | 0.02% | 718 |
|
|
2020
Q3 | $7.69M | Sell |
107,900
-12,900
| -11% | -$919K | 0.02% | 613 |
|
|
2020
Q2 | $9.94M | Buy |
120,800
+2,700
| +2% | +$222K | 0.03% | 555 |
|
|
2020
Q1 | $6.95M | Buy |
118,100
+91,400
| +342% | +$5.38M | 0.03% | 605 |
|
|
2019
Q4 | $2.76M | Buy |
+26,700
| New | +$2.76M | 0.01% | 1077 |
|